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doi:10.1016/j.ejvs.2009.03.019Abstract Background and purpose: This study aimed to investigate the embolic potential of
carotid plaques, employing both the presence and the rate of micro-embolic signals (MESs),
based on the presence and timing (current or past) of symptoms, degree of stenosis and ultra-
sonic characteristics of plaques.
Methods: We used the transcranial Doppler (TCD) to monitor MES and the Doppler ultrasound
to classify carotid plaques in newly symptomatic (acute stroke or transient ischaemic attack
(TIA)), formerly symptomatic (relevant stroke or TIA per anamnesis) and asymptomatic
patients with internal carotid artery (ICA) stenosis.
Results: Stroke-related arteries evidenced a significantly greater presence of MES than the
TIA-related and asymptomatic arteries (pZ 0.04), with no significant difference found
between the latter two groups (stroke: 42/90, 46.7%; TIA: 15/49, 30.6%; asymptomatic: 40/
130, 30.8%). Adjustment for anti-platelet treatment did not change this finding. The degree
of stenosis, ultrasonic characteristics of texture and the density of plaques were not found
to be associated with the presence or quantity of MES.
Conclusion: MESs are present significantly more often in stenosed, stroke-related carotid
arteries as compared with TIA-related or asymptomatic arteries. Neither the ultrasonic char-
acteristics nor the degree of stenosis were found to influence the presence or rate of MES.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.PhD, MD. Department of
pus, Haifa, Israel. Tel.: þ972
.health.gov.il (G. Telman).
ty for Vascular Surgery. PublisheDifferent aspects of monitoring of micro-embolic signals
(MESs) in patients with atherosclerotic disease of the
internal carotid artery (ICA) are reflected in the literature.
Despite the increasing degree of research attentiond by Elsevier Ltd. All rights reserved.
Table 1 Distribution of vascular risk factors in patients
included into the study
Risk factor Number (percentage)
Hypertension 183 (80%)
Diabetes 83 (36%)
Hyperlipidaemia 164 (72%)
Smoking 100 (43%)
Ischaemic heart disease 111 (48%)
Atrial fibrillation 12 (5%)
144 G. Telman et al.devoted to this problem, controversies still remain about
which factors determine the presence and rate of MES. This
study aimed to investigate different factors which may
influence both the presence and the rate of MES in patients
with ICA atherosclerotic disease. Specifically, the presence
(symptomatic vs. asymptomatic) and timing (current or
past) of symptoms, the degree of stenosis and the ultra-
sonic characteristics of the plaques were examined.
Patients and Methods
Patients
The study cohort consisted of all patients suffering from
carotid stenosis who underwent transcranial Doppler (TCD)
examination, MES monitoring and cervical duplex at the
Rambam Health Care Campus in Haifa, Israel. Data were
prospectively collected for a total of 229 patients, including
110 patients from the department of neurology, 74 patients
from the department of vascular surgery and 45 patients
from the department of invasive cardiology. A total of 269
arteries, in which duplex showed carotid plaques, were
included in the final analysis.
With regard to the degree of stenosis, duplex revealed 64
arteries with mild (less than 50%) stenosis of the ICA, 56
arteries with moderate (50e69%) stenosis and 149 arteries
with severe (70e99%) stenosis. As for the presence and timing
of symptoms, there were 130 asymptomatic arteries e 39
formerly symptomatic (transient ischaemic attack (TIA) or
stroke in the past, including 26 TIA- and 13 stroke-related
arteries; timerange fromindexevent5e91months)eand100
newly symptomatic arteries (23 TIA- and 77 stroke-related,
examined during the first 96 h after admission). Because
patients couldhaveboth a symptomatic and anasymptomatic
artery, neither a simple categorisation of patients as ‘symp-
tomatic’ or ‘asymptomatic’ nor a corresponding grouping by
demographic characteristics and risk factors was possible.
MES monitoring
MES monitoring by TCD (Pioneer TC 8080, Nicolett Vyasys,
USA) was performed at the level of the middle cerebral
artery (MCA) on the side of the carotid stenosis (detected
previously by cervical duplex) through the temporal window
by an operator (E.K.). The duration of monitoring was
30 min, and the parameters used for the monitoring have
been described earlier.1 A threshold of 6 dB was chosen for
embolus detection. The depth of insonation was 48e65 mm
forMCA stemvisualisation;monitoringwas done at the depth
which displayed the best flow signal. Single-gate mode was
used for monitoring. Detection of the MES was based on the
differences between MES and blood-flow intensities, in
accordance with accepted criteria.2 We used an automatic
embolus detection system, but MESs were re-examined by
one of the authors (E.K) off-line afterwards, and those MESs
which were recognised as artefacts were rejected.
Cervical duplex and plaque analysis
A single operator (E.K.) performed all duplex ultrasound
(DU) examinations with a 4e8 linear array probe by usingthe HD 11 Philips Ultrasound system (The Netherlands). The
common carotid artery, ICA, carotid bifurcation and
external carotid artery were examined by B-mode and
colour-flow modalities. The maximal peak systolic velocity
(PSV) and end-diastolic velocity (EDV) were recorded from
each location. The grading of severe carotid stenosis was
calculated according to an international consensus.3
According to the results of the B-mode imaging, the types
of plaques were marked as either homogeneous or
heterogeneous. In turn, the homogeneous plaques were
defined as isoechoic, hypoechoic or hyperechoic.4,5
Density of plaques
The B-mode settings were adjusted to obtain a clear image
of the vessel lumen as well as of the echo-dense area of the
adventitia close to the plaque. Images were stored on
a compact disc (CD) and then standardised on a personal
computer. Adobe Photoshop 7.0 (Adobe Systems, San Jose,
CA, USA) was used to calculate the density of plaques by
grey-scale median (GSM) scores, as previously described in
the literature.6
Statistics
Statistical analysis consisted of chi-square and analysis of
variance (ANOVA) for categorical and continuous outcome
variables, respectively. A multivariate logistic regression
model for the presence of MES using age, sex, hypertension,
diabetes, hyperlipidaemia, smoking, atrial fibrillation (AF),
symptomaticity (TIA, stroke, asymptomatic, etc.), texture
characteristics, plaque density and severity of stenosis was
tested. In order to control for the effects of anti-platelet
treatment, separate logistic regression analyses were also
conducted. Both JMP and Statistical Analysis Software (SAS,
SAS Institute, Cary, NC, USA) were used for the statistical
analyses.
Results
The patients’ age ranged from 28 to 93 years, with
a median of 68 years. There were 178 male and 51 female
patients. The distribution of the main vascular risk factors
for the whole group is presented in Table 1. Table 2 pres-
ents the distribution of anti-platelets and statin treatments
in different patient groups. All analyses and correlations
were performed for plaque-bearing arteries and not for
patients. Actual results of the MES monitoring (by arteries)
are presented in Table 3.
Table 2 Details of treatment in different groups of patients
Treatment/
category of
patients
Aspirin Clopidogrel Aspirinþ
Clopidogrel
Statins
TIA 34 (73.9%) 1 (2.2%) 6 (13%) 32 (69.6%)
Stroke 39 (50.7%) 8 (10.4%) 4 (5.2%) 38 (49.4%)
Asymptomatic 57 (54.8%) 5 (4.8%) 21 (20.2%) 70 (67.3%)
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When we compared all stroke-related, TIA-related and
asymptomatic arteries, the stroke-related arteries evi-
denced a significantly greater presence of MES (as evalu-
ated by on/off criteria) than the other two groups
(pZ 0.04), with no differences found between the
asymptomatic and the TIA-related arteries (stroke-related
arteries: 42/90, 46.7%; asymptomatic-related arteries: 40/
130, 30.8%; TIA-related arteries: 15/49, 30.6%). No differ-
ences were found between newly symptomatic and
formerly symptomatic arteries, either including or
excluding those that were TIA-related. A multivariate
logistic regression model for the presence of MES using age,
sex, hypertension, diabetes, hyperlipidaemia, smoking, AF,
symptomaticity (TIA, stroke, asymptomatic, etc.), texture
characteristics, plaque density and severity of stenosis was
not significant.
We also performed an adjustment based on treatment
with anti-platelets, including both symptomaticity and
treatment, using logistic regression models for the pres-
ence of MES. The results showed that significant differences
between asymptomatic and stroke-related arteries were
still present (pZ 0.03).
When the relationship between symptomaticity and the
number of MES was examined, no differences were found
between the groups when the TIA- and the stroke-related
arteries were considered as a single symptomatic group
(asymptomatic-related arteries: 1.2 0.2; symptomatic-
related, including TIA-related: 2.0 0.5; NS). However,
when we removed the TIA-related arteries from the anal-
yses, we found a significant difference in the mean rate of
MES in the stroke-related arteries as compared with the
asymptomatic-related arteries (stroke-related: 1.7 0.5;
asymptomatic-related: 0.8 0.2; pZ 0.04).Table 3 Actual results of MES monitoring (by arteries) dependi
Number of MES/artery and
plaque characteristic
0 1 2 3 4
Mild stenosis 39 14 3 3 e
Moderate stenosis 38 9 5 e e
Severe stenosis 95 23 17 3 3
Asymptomatic-related 90 18 12 3 e
Stroke-related 46 24 8 2 1
TIA-related 34 4 5 1 2
Heterogeneous 101 27 15 3 3
Homogeneous, anechoic 41 11 5 2 2
Homogeneous, hyperechoic 16 6 2 e e
Homogeneous, isoechoic 14 1 3 1 1MES and severity of stenosis
The severity of stenosis was not associated with the pres-
ence of MES (arteries with mild stenosis: 25/64, 39.1%;
arteries with moderate stenosis: 18/56, 32.1%; arteries
with severe stenosis: 54/149, 36.2%; NS). Moreover,
severity had no influence on the number of MESs (mean
standard error e arteries with mild stenosis: 1.4 0.6;
arteries with moderate stenosis: 1.5 0.6; arteries with
severe stenosis: 0.8 0.2; NS).
MES and texture of plaques
There was no influence of ultrasonic texture characteristics
or plaque density on the presence of MES (see Table 4).
The texture of plaques also had no influence on the
number of MESs (mean standard error e heterogeneous:
1.3 0.3; homogeneous anechoic: 0.8 0.3; homogeneous
hyperechoic: 1.3 0.7; homogeneous isoechoic: 0.7 0.3;
NS). Logistic regression adjustment for anti-platelet
treatment did not change any of the previous non-signifi-
cant results related to the degree of stenosis or the
ultrasonic characteristics. Finally, there was no correlation
found between the density of plaques and the number of
MESs (rZ 0.012; NS).
Discussion
There are substantial data in the literature on different
aspects of carotid stenosis influencing the presence and
rate of MES. However, the results are mixed, and there are
few comprehensive studies exploring all aspects of carotid
disease as a complex problem in a representative cohort of
patients. This study presents data on the influence ofng on arteries’ characteristics
5 6e10 11e20 30e50 More than 50
e 2 1 1 1
e 1 2 1 e
e 8 e e e
e 7 e e e
e 2 2 2
e 2 1 e 1
e 9 1 2 1
e 1 1 e e
e 1 1 e e
e e e e e
Table 4 Ultrasonic characteristics of plaque texture and
presence of MES
Texture of plaque MESþ MES p
Heterogeneous 58, 36.48% 101, 63.52% NS
Homogenous, Anechoic 22, 34.92% 41, 65.08% NS
Homogenous, Hyperechoic 10, 38.46% 16, 61.54% NS
Homogenous, Isoechoic 6, 30.00% 14, 70.00% NS
Plaque density 79.0 53.0 74.4 51.1 NS
Note: Texture data for one artery (one patient) is missing from
our database.
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ultrasonic characteristics on the presence and rate of MES.
The few studies in the literature on the interrelation
between the ultrasonic texture of plaques and the presence
of MES have yielded contradictory results. Mayor et al.,7
showed that anechogenic/hypoechogenic plaques are
associated with the presence of MES, whereas Sztajzel
et al.,8 revealed that a low mean GSM value of plaque is
associated with MES. In the present study, we were unable
to establish any association between qualitative (type of
plaque) or quantitative (density of plaque) ultrasonic
characteristics and the presence or rate of MES. This finding
is in line with the results of another large study9 on patients
suffering from severe carotid stenosis.
The correlation between the degree of stenosis and MES
has been previously studied, with somewhat controversial
results and a clear understanding that factors other than
the degree of stenosis are also important in determining
high-risk carotid plaque.10 Babikian and colleagues
concluded that MESs are significantly more common distal
to lesions, causing anywhere from 50% to more than 70% of
ICA stenosis.11,12 Orlandi et al.,13 found that MESs were
significantly more frequent in patients with a higher degree
of carotid stenosis, and Droste et al.,14 showed that both
positivity for the presence and the number of MESs
increased in relation to the rising degree of stenosis. Similar
results were shown by Akiyama et al.,15 Siebler et al.16 and
Gao et al.17 The main limitation of all the above-mentioned
studies, with the exception of one,12 is the small number of
patients and arteries studied. Our study did not reveal an
association between the presence of MES and an increasing
degree of carotid stenosis. Other studies also point to the
absence of such dependence18 or to insufficient statistical
significance of relations between the degree of stenosis and
the presence of MES.19
The most interesting and important aspect of MES
monitoring in patients with carotid stenosis is the possible
association between MES and the presence or absence of
clinical manifestations. It seems well established that there
is an association between the presence of symptoms and
a greater rate of MES.14,20e22 This finding was confirmed in
the present study as well. However, there are two inter-
esting points to be noted based on our results: first,
contrary to Forteza et al.,23 we found that TIA-related
arteries were significantly less emboliogenic than stroke-
related arteries; second, we did not find any differences in
the presence or the rate of MES between new and former
stroke-related arteries. This finding contradicts the well-
established fact that the most emboliogenic period in thegeneral stroke population is close to the acute stroke,24 and
can be partially explained by the small sample size of
patients with stroke in the past. There are some limitations
of our study. First, the ultrasonographer was not blinded to
the clinical status of patients, though any possible bias
would have been controlled by the automatic online
embolus detection system used. Second, we were also
unable to exclude the cardiac origin of emboli because TEE
was not a part of the study protocol. Finally, the multi-
variate logistic regression model was not significant,
perhaps due to the insufficient sample size.
In conclusion, we can summarise that stroke-related
arteries (acute or in the past) are associated with a higher
presence of MES, while there is no influence of the ultra-
sonic texture, density of plaques or degree of stenosis on
the presence and the rate of MES.
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